Jenburkt Pharmaceuticals Ltd — Insider Trading, 22-09-2025: Insider Trading / SAST

Jenburkt Pharmaceuticals Limited has initiated the closure of its trading window for designated persons, insiders, and their relatives, starting October 1st. This action precedes the announcement of the financial results for the quarter and half-year ending September 30th, 2025. The window will reopen 48 hours after these results are publicly disseminated. The company will separately communicate the board meeting schedule to consider the financial figures. This is a common practice to ensure fair trading before sensitive financial information is released.